Back to Search
Start Over
Supplementary Data from Phase Ib Study of Enzalutamide in Combination with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplemental Table 1. Reasons for docetaxel discontinuation Supplemental Figure 1. Safety and PK assessment schedule
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....be43aefda7a2aa5f81d20cae72db4fc3
- Full Text :
- https://doi.org/10.1158/1078-0432.22454636